Annual revenue:
$5.44B+$429.50M(+8.57%)Summary
- As of today (April 18, 2025), EW annual revenue is $5.44 billion, with the most recent change of +$429.50 million (+8.57%) on December 1, 2024.
- During the last 3 years, EW annual revenue has risen by +$207.00 million (+3.96%).
- EW annual revenue is now at all-time high.
Performance
EW Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$1.39B+$31.40M(+2.32%)Summary
- As of today (April 18, 2025), EW quarterly revenue is $1.39 billion, with the most recent change of +$31.40 million (+2.32%) on December 1, 2024.
- Over the past year, EW quarterly revenue has increased by +$31.40 million (+2.32%).
- EW quarterly revenue is now -13.29% below its all-time high of $1.60 billion, reached on March 31, 2024.
Performance
EW Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$5.72B+$119.40M(+2.13%)Summary
- As of today (April 18, 2025), EW TTM revenue is $5.72 billion, with the most recent change of +$119.40 million (+2.13%) on December 1, 2024.
- Over the past year, EW TTM revenue has increased by +$119.40 million (+2.13%).
- EW TTM revenue is now at all-time high.
Performance
EW TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EW Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.6% | +2.3% | +2.1% |
| 3 y3 years | +4.0% | +2.3% | +2.1% |
| 5 y5 years | +25.1% | +18.0% | +27.7% |
EW Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +21.9% | -13.3% | +222.3% | at high | +29.3% |
| 5 y | 5-year | at high | +25.1% | -13.3% | +222.3% | at high | +32.5% |
| alltime | all time | at high | +685.9% | -13.3% | +837.6% | at high | +2432.9% |
Edwards Lifesciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $5.44B(+8.6%) | $1.39B(+2.3%) | $5.72B(+2.1%) |
| Sep 2024 | - | $1.35B(-2.3%) | $5.60B(+2.0%) |
| Jun 2024 | - | $1.39B(-13.3%) | $5.49B(+1.7%) |
| Mar 2024 | - | $1.60B(+26.2%) | $5.40B(+2.6%) |
| Dec 2023 | $5.01B(+12.2%) | $1.27B(+1.8%) | $5.26B(+18.9%) |
| Sep 2023 | - | $1.24B(-4.0%) | $4.43B(-1.7%) |
| Jun 2023 | - | $1.30B(-11.2%) | $4.50B(-1.7%) |
| Mar 2023 | - | $1.46B(+239.5%) | $4.58B(+2.7%) |
| Dec 2022 | $4.46B(-14.7%) | $429.90M(-67.4%) | $4.46B(-16.8%) |
| Sep 2022 | - | $1.32B(-4.0%) | $5.36B(+0.2%) |
| Jun 2022 | - | $1.37B(+2.4%) | $5.36B(-0.0%) |
| Mar 2022 | - | $1.34B(+0.9%) | $5.36B(+2.4%) |
| Dec 2021 | $5.23B(+19.3%) | $1.33B(+1.5%) | $5.23B(+2.7%) |
| Sep 2021 | - | $1.31B(-4.8%) | $5.09B(+3.4%) |
| Jun 2021 | - | $1.38B(+13.1%) | $4.93B(+10.1%) |
| Mar 2021 | - | $1.22B(+2.1%) | $4.47B(+2.0%) |
| Dec 2020 | $4.39B(+0.9%) | $1.19B(+4.5%) | $4.39B(+0.4%) |
| Sep 2020 | - | $1.14B(+23.3%) | $4.37B(+1.1%) |
| Jun 2020 | - | $925.00M(-18.0%) | $4.32B(-3.6%) |
| Mar 2020 | - | $1.13B(-3.9%) | $4.48B(+3.1%) |
| Dec 2019 | $4.35B(+16.8%) | $1.17B(+7.3%) | $4.35B(+4.7%) |
| Sep 2019 | - | $1.09B(+0.7%) | $4.15B(+4.7%) |
| Jun 2019 | - | $1.09B(+9.5%) | $3.96B(+3.7%) |
| Mar 2019 | - | $993.00M(+1.6%) | $3.82B(+2.6%) |
| Dec 2018 | $3.72B(+8.4%) | $977.70M(+7.8%) | $3.72B(+2.5%) |
| Sep 2018 | - | $906.60M(-3.9%) | $3.63B(+2.4%) |
| Jun 2018 | - | $943.70M(+5.5%) | $3.55B(+3.0%) |
| Mar 2018 | - | $894.80M(+0.7%) | $3.45B(+0.3%) |
| Dec 2017 | $3.44B(+15.9%) | $888.50M(+8.2%) | $3.44B(+3.6%) |
| Sep 2017 | - | $821.50M(-2.4%) | $3.31B(+2.5%) |
| Jun 2017 | - | $841.80M(-4.7%) | $3.23B(+2.6%) |
| Mar 2017 | - | $883.50M(+15.1%) | $3.15B(+6.3%) |
| Dec 2016 | $2.96B(+18.8%) | $767.70M(+3.8%) | $2.96B(+3.4%) |
| Sep 2016 | - | $739.40M(-2.6%) | $2.87B(+4.5%) |
| Jun 2016 | - | $759.30M(+8.9%) | $2.74B(+5.5%) |
| Mar 2016 | - | $697.30M(+3.9%) | $2.60B(+4.3%) |
| Dec 2015 | $2.49B(+7.4%) | $671.10M(+9.0%) | $2.49B(+2.2%) |
| Sep 2015 | - | $615.50M(-0.2%) | $2.44B(+0.3%) |
| Jun 2015 | - | $616.80M(+4.5%) | $2.43B(+1.7%) |
| Mar 2015 | - | $590.30M(-4.5%) | $2.39B(+2.9%) |
| Dec 2014 | $2.32B(+13.6%) | $618.00M(+1.7%) | $2.32B(+3.7%) |
| Sep 2014 | - | $607.40M(+5.6%) | $2.24B(+5.3%) |
| Jun 2014 | - | $575.10M(+10.1%) | $2.13B(+2.8%) |
| Mar 2014 | - | $522.40M(-2.5%) | $2.07B(+1.3%) |
| Dec 2013 | $2.05B(+7.7%) | $536.00M(+8.2%) | $2.05B(+1.3%) |
| Sep 2013 | - | $495.60M(-4.2%) | $2.02B(+2.4%) |
| Jun 2013 | - | $517.20M(+4.1%) | $1.97B(+1.8%) |
| Mar 2013 | - | $496.70M(-2.7%) | $1.94B(+2.0%) |
| Dec 2012 | $1.90B | $510.50M(+14.0%) | $1.90B(+4.4%) |
| Sep 2012 | - | $447.90M(-7.1%) | $1.82B(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $482.00M(+5.0%) | $1.78B(+2.9%) |
| Mar 2012 | - | $459.20M(+6.7%) | $1.73B(+3.3%) |
| Dec 2011 | $1.68B(+16.0%) | $430.20M(+4.2%) | $1.68B(+2.3%) |
| Sep 2011 | - | $412.70M(-4.3%) | $1.64B(+4.0%) |
| Jun 2011 | - | $431.20M(+6.6%) | $1.58B(+4.4%) |
| Mar 2011 | - | $404.50M(+3.1%) | $1.51B(+4.4%) |
| Dec 2010 | $1.45B(+9.5%) | $392.40M(+12.5%) | $1.45B(+3.3%) |
| Sep 2010 | - | $348.90M(-4.5%) | $1.40B(+1.7%) |
| Jun 2010 | - | $365.20M(+7.3%) | $1.38B(+2.2%) |
| Mar 2010 | - | $340.50M(-1.8%) | $1.35B(+2.0%) |
| Dec 2009 | $1.32B(+6.8%) | $346.70M(+6.4%) | $1.32B(+2.9%) |
| Sep 2009 | - | $325.70M(-2.9%) | $1.28B(+1.8%) |
| Jun 2009 | - | $335.50M(+7.0%) | $1.26B(+0.6%) |
| Mar 2009 | - | $313.50M(+1.2%) | $1.25B(+1.3%) |
| Dec 2008 | $1.24B(+13.4%) | $309.70M(+2.0%) | $1.24B(+1.4%) |
| Sep 2008 | - | $303.60M(-7.3%) | $1.22B(+3.6%) |
| Jun 2008 | - | $327.60M(+10.4%) | $1.18B(+4.9%) |
| Mar 2008 | - | $296.80M(+1.3%) | $1.12B(+3.0%) |
| Dec 2007 | $1.09B(+5.2%) | $293.00M(+12.1%) | $1.09B(+2.6%) |
| Sep 2007 | - | $261.40M(-4.1%) | $1.06B(+1.3%) |
| Jun 2007 | - | $272.60M(+3.2%) | $1.05B(+0.5%) |
| Mar 2007 | - | $264.10M(-0.6%) | $1.04B(+0.7%) |
| Dec 2006 | $1.04B(+3.9%) | $265.60M(+7.4%) | $1.04B(+1.6%) |
| Sep 2006 | - | $247.40M(-7.4%) | $1.02B(+0.6%) |
| Jun 2006 | - | $267.30M(+4.0%) | $1.01B(+0.9%) |
| Mar 2006 | - | $257.00M(+2.9%) | $1.01B(+0.8%) |
| Dec 2005 | $997.90M(+7.1%) | $249.70M(+3.7%) | $997.90M(+1.3%) |
| Sep 2005 | - | $240.90M(-6.7%) | $985.30M(+1.7%) |
| Jun 2005 | - | $258.20M(+3.7%) | $969.20M(+2.5%) |
| Mar 2005 | - | $249.10M(+5.1%) | $945.60M(+1.5%) |
| Dec 2004 | $931.50M(+8.3%) | $237.10M(+5.5%) | $931.50M(+1.4%) |
| Sep 2004 | - | $224.80M(-4.2%) | $918.50M(+2.1%) |
| Jun 2004 | - | $234.60M(-0.2%) | $899.80M(+1.9%) |
| Mar 2004 | - | $235.00M(+4.9%) | $883.00M(+2.6%) |
| Dec 2003 | $860.50M(+22.2%) | $224.10M(+8.7%) | $860.50M(+2.5%) |
| Sep 2003 | - | $206.10M(-5.4%) | $839.50M(+5.0%) |
| Jun 2003 | - | $217.80M(+2.5%) | $799.20M(+6.0%) |
| Mar 2003 | - | $212.50M(+4.6%) | $754.20M(+7.1%) |
| Dec 2002 | $704.00M(+1.7%) | $203.10M(+22.5%) | $704.00M(+6.5%) |
| Sep 2002 | - | $165.80M(-4.1%) | $660.90M(+2.8%) |
| Jun 2002 | - | $172.80M(+6.5%) | $642.90M(-3.0%) |
| Mar 2002 | - | $162.30M(+1.4%) | $662.50M(-4.3%) |
| Dec 2001 | $692.10M(-13.9%) | $160.00M(+8.3%) | $692.10M(-7.5%) |
| Sep 2001 | - | $147.80M(-23.2%) | $748.60M(-4.8%) |
| Jun 2001 | - | $192.40M(+0.3%) | $786.60M(-1.6%) |
| Mar 2001 | - | $191.90M(-11.4%) | $799.20M(-4.1%) |
| Dec 2000 | $804.00M(-11.2%) | $216.50M(+16.5%) | $833.30M(+35.1%) |
| Sep 2000 | - | $185.80M(-9.4%) | $616.80M(+43.1%) |
| Jun 2000 | - | $205.00M(-9.3%) | $431.00M(+90.7%) |
| Mar 2000 | - | $226.00M | $226.00M |
| Dec 1999 | $905.00M | - | - |
FAQ
- What is Edwards Lifesciences annual revenue?
- What is the all time high annual revenue for Edwards Lifesciences?
- What is Edwards Lifesciences annual revenue year-on-year change?
- What is Edwards Lifesciences quarterly revenue?
- What is the all time high quarterly revenue for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly revenue year-on-year change?
- What is Edwards Lifesciences TTM revenue?
- What is the all time high TTM revenue for Edwards Lifesciences?
- What is Edwards Lifesciences TTM revenue year-on-year change?
What is Edwards Lifesciences annual revenue?
The current annual revenue of EW is $5.44B
What is the all time high annual revenue for Edwards Lifesciences?
Edwards Lifesciences all-time high annual revenue is $5.44B
What is Edwards Lifesciences annual revenue year-on-year change?
Over the past year, EW annual revenue has changed by +$429.50M (+8.57%)
What is Edwards Lifesciences quarterly revenue?
The current quarterly revenue of EW is $1.39B
What is the all time high quarterly revenue for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly revenue is $1.60B
What is Edwards Lifesciences quarterly revenue year-on-year change?
Over the past year, EW quarterly revenue has changed by +$31.40M (+2.32%)
What is Edwards Lifesciences TTM revenue?
The current TTM revenue of EW is $5.72B
What is the all time high TTM revenue for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM revenue is $5.72B
What is Edwards Lifesciences TTM revenue year-on-year change?
Over the past year, EW TTM revenue has changed by +$119.40M (+2.13%)